These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30877856)

  • 21. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
    van Haelst IM; van Klei WA; Doodeman HJ; Warnier MJ; De Bruin ML; Kalkman CJ; Egberts TC
    J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effect of citalopram, bupropion, sertraline, and tricyclic antidepressants on QTc: A cross-sectional study.
    Straley CM; Sochacki M; Reed E; Carr CN; Baugh TB
    J Affect Disord; 2022 Jan; 296():476-484. PubMed ID: 34649181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers.
    Kim A; Lim KS; Lee H; Chung H; Yoon SH; Yu KS; Cho JY; Jang IJ; Chung JY
    Int Clin Psychopharmacol; 2016 Jul; 31(4):210-7. PubMed ID: 26950553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
    Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T
    Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
    Beach SR; Kostis WJ; Celano CM; Januzzi JL; Ruskin JN; Noseworthy PA; Huffman JC
    J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population-based cohort study in older adults.
    Aakjaer M; Werther SK; De Bruin ML; Andersen M
    Clin Transl Sci; 2022 Sep; 15(9):2105-2115. PubMed ID: 35733364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Escitalopram-induced QTc prolongation and its relationship with KCNQ1, KCNE1, and KCNH2 gene polymorphisms.
    Chen Z; Xu Z; Gao C; Chen L; Tan T; Jiang W; Chen B; Yuan Y; Zhang Z
    J Affect Disord; 2024 Feb; 347():399-405. PubMed ID: 38000475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QTc interval prolongation associated with citalopram overdose: a case report and literature review.
    Catalano G; Catalano MC; Epstein MA; Tsambiras PE
    Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and ECG effects of escitalopram overdose.
    van Gorp F; Whyte IM; Isbister GK
    Ann Emerg Med; 2009 Sep; 54(3):404-8. PubMed ID: 19556032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium channel blockade with QRS widening after an escitalopram overdose.
    Schreffler SM; Marraffa JM; Stork CM; Mackey J
    Pediatr Emerg Care; 2013 Sep; 29(9):998-1001. PubMed ID: 24201980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Evaluation of the QTc Interval and Antidepressants in Youth: An Electronic Health Record Study.
    Uchida M; Spencer AE; Biederman J; Castro VM; Kenworthy T; Chan J; Rosales AM; Newton-Cheh C; Perlis RH
    J Dev Behav Pediatr; 2015; 36(6):434-9. PubMed ID: 26154713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Pilot Study: Cardiac Parameters in Children Receiving New-Generation Antidepressants.
    Uchida M; Spencer AE; Kenworthy T; Chan J; Fitzgerald M; Rosales AM; Kagan E; Saunders A; Biederman J
    J Clin Psychopharmacol; 2017 Jun; 37(3):359-362. PubMed ID: 28301398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs.
    Chastang A; Renet S; Corny J; Beaussier H; Petre A; Lillo-Lelouet A; Phan Thi TT; Bézie Y
    Int J Clin Pharm; 2019 Feb; 41(1):42-48. PubMed ID: 30610545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data.
    de Bardeci M; Greil W; Stassen H; Willms J; Köberle U; Bridler R; Hasler G; Kasper S; Rüther E; Bleich S; Toto S; Grohmann R; Seifert J
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):65-74. PubMed ID: 35217913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citalopram & escitalopram: Mechanisms of cardiotoxicity, toxicology predisposition and risks of use in geriatric & hemodialysis populations.
    Farhat H; Tlaiss Y; Nassif L; Gutlapalli SD; Abdulaal R
    Glob Cardiol Sci Pract; 2024 Aug; 2024(4):e202434. PubMed ID: 39351473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation.
    Kim Y; Kim A; Chung JY
    J Affect Disord; 2021 Apr; 285():120-126. PubMed ID: 33647579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.
    Wu E; Greenberg P; Yang E; Yu A; Ben-Hamadi R; Erder MH
    Curr Med Res Opin; 2008 Oct; 24(10):2805-13. PubMed ID: 18755054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citalopram and cardiac toxicity.
    Cooke MJ; Waring WS
    Eur J Clin Pharmacol; 2013 Apr; 69(4):755-60. PubMed ID: 22996077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.